• EZ Cap™ Human PTEN mRNA: Data-Driven Solutions for Tumor Sup

  2026-06-19

  This article delivers scenario-based, evidence-backed guidance for leveraging EZ Cap™ Human PTEN mRNA (SKU R1025) to overcome key challenges in cancer research and gene therapy workflows. By grounding recommendations in laboratory pain points and published data, we demonstrate how this rigorously validated tumor suppressor gene mRNA supports reproducible, sensitive, and efficient mRNA transfection experiments.

• ICG001: Selective Wnt/β-Catenin Inhibitor for Advanced Regen

  2026-06-19

  Unlock the power of ICG001, a potent Wnt/β-catenin pathway inhibitor, in regenerative medicine and disease modeling. This article delivers advanced insights into its mechanism, protocols, and emerging applications, offering a deeper scientific perspective than standard reviews.

• PR-619: Broad-Spectrum Deubiquitylating Enzymes Inhibitor in

  2026-06-18

  PR-619 delivers unmatched flexibility for ubiquitination pathway research by reversibly inhibiting a wide range of cysteine-dependent DUBs without affecting proteasome activity. This versatile compound streamlines workflows in cancer and neurodegeneration models, and APExBIO’s high-purity formulation ensures reproducibility in even the most demanding cell-based assays.

• IWR-1-endo: A Precision Wnt Signaling Inhibitor for Reliable

  2026-06-18

  IWR-1-endo empowers researchers to selectively inhibit the Wnt/β-catenin pathway, delivering nanomolar potency and reproducibility in cancer and stem cell models. With optimized workflows, troubleshooting guidance, and cross-domain validation, this APExBIO reagent stands out for its robust performance in colorectal cancer and regenerative research.

• AO/PI Staining Solution: Precision Fluorescent Cell Viabilit

  2026-06-17

  AO/PI Staining Solution empowers researchers with high-fidelity live/dead cell discrimination, overcoming limitations of traditional stains in cytotoxicity and apoptosis workflows. Its optimized dual-dye formulation ensures robust, interference-free quantification—making it indispensable for advanced fluorescence-based cell counting and membrane integrity assays.

• Dual Glutamate Receptor Blockade Mitigates Soman-Induced Neu

  2026-06-17

  The reference study demonstrates that dual AMPA/NMDA receptor antagonism with IEM-1925 effectively suppresses status epilepticus, protects hippocampal neurons, and improves cognition in a rat model of soman exposure. This work advances understanding of targeted excitotoxicity interventions and informs translational design for neuroprotection assays.

• XAV-939: Strategic Modulation of Wnt/β-Catenin for Translati

  2026-06-16

  This article explores the mechanistic rationale and translational strategy for deploying XAV-939 (NVP-XAV939) in research targeting Wnt/β-catenin signaling. Drawing on recent literature, competitive insights, and practical protocols, it provides guidance for leveraging XAV-939 in cancer, fibrotic, and bone biology research, while outlining future directions for precision medicine.

• Perospirone Inhibits Kv1.5 Channels in Coronary Arterial Cel

  2026-06-16

  A recent study reveals that Perospirone, a second-generation antipsychotic, inhibits vascular Kv1.5 channels in coronary arterial smooth muscle cells, suggesting a novel off-target effect. This finding has important implications for both schizophrenia research and the cardiovascular safety evaluation of serotonergic and dopaminergic antagonists.

• Praeruptorin A: Mechanistic Benchmarks for Inflammation Rese

  2026-06-15

  Praeruptorin A, an angular pyranocoumarin compound, demonstrates robust anti-inflammatory and ferroptosis-inhibiting effects via multi-targeted molecular modulation. It downregulates key cytokines and pathways implicated in macrophage-driven inflammation and shows application potential in ulcerative colitis and cancer metastasis models.

• Stattic: STAT3 Inhibitor for HNSCC Research and Radiosensiti

  2026-06-15

  Stattic is a selective STAT3 inhibitor that enables precise dissection of STAT3-mediated signaling, apoptosis induction, and radiosensitization in head and neck squamous cell carcinoma (HNSCC) research. This article delivers actionable workflows, troubleshooting strategies, and translational insights for maximizing the impact of Stattic, featuring protocol optimization rooted in the latest mechanistic advances.

• Methicillin Sodium Salt: Advanced Workflows for MSSA Researc

  2026-06-14

  Methicillin sodium salt empowers laboratories to design highly controlled Staphylococcus aureus infection models and resistance profiling assays. This guide translates state-of-the-art research and product specifications into actionable protocols, troubleshooting tips, and comparative insights for gram-positive infection workflows.

• siRNA Nanoparticles Target TDRD9 to Mitigate P. aeruginosa L

  2026-06-13

  This study demonstrates that hyaluronic acid-coated siRNA nanoparticles targeting Tudor domain-containing protein 9 (TDRD9) promote neutrophil cuproptosis, reducing lung injury in preclinical Pseudomonas aeruginosa pneumonia models. The findings advance understanding of neutrophil-mediated immune modulation and highlight a promising therapeutic platform for multidrug-resistant bacterial infections.

• Grazoprevir/Elbasvir: Efficacy and Advances in HCV Genotype

  2026-06-12

  This review evaluates the fixed-dose combination of Grazoprevir (MK-5172 hydrate) and Elbasvir for hepatitis C virus infection, highlighting its potent antiviral activity and favorable safety in diverse patient groups. The findings inform both clinical and laboratory research on direct-acting antivirals, especially for challenging populations such as those with HIV coinfection or chronic kidney disease.

• CHIR-99021 (CT99021): Optimizing Stem Cell and Differentiati

  2026-06-12

  CHIR-99021 (CT99021) stands apart as a selective GSK-3 inhibitor empowering precise Wnt/β-catenin pathway modulation in stem cell research and regenerative models. This article delivers a protocol-driven perspective, practical troubleshooting, and actionable insights grounded in recent mechanistic findings and benchmarked use-cases.

• TCAIM Regulates Mitochondrial Metabolism by Targeting OGDH

  2026-06-11

  Wang et al. (2025) identify TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds and reduces a-ketoglutarate dehydrogenase (OGDH) protein levels, thereby modulating mitochondrial metabolism and energy production. This study unveils a noncanonical, post-translational mechanism for controlling a key TCA cycle enzyme, with implications for targeted metabolic research and disease modeling.

15737 records 1/1050 page Next 12345 下5页 Last page